Topical steroids for vitiligo

The following local adverse reactions are reported infrequently when topical corticosteroids are used as recommended. These reactions are listed in an approximately decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, manifestations of Cushing syndrome, hyperglycemia, and glucosuria in some patients. In rare instances, treatment (or withdrawal of treatment) of psoriasis with corticosteroids is thought to have exacerbated the disease or provoked the pustular form of the disease, so careful patient supervision is recommended.

Pseudocatalase - There are 2 forms of pseudocatalase (PCat) - They are PC-KUS, developed by Dr. Karin Schallreuter, and PCAT, available only through a few compounding pharmacies in the US and Canada. Dr. Schallreuter's formula is only available through an initial consultation at her clinic in Griefswald, Germany. The two formulas are similar in nature, though Dr Schallreuter's formula is specific to the individual. PCat is typically applied to the entire body twice per day. NB-UVB is used for a very brief period of 15 seconds or so to activate the medication.

This report is another study that demonstrates the success of topical steroid therapy in an effort to avoid circumcision under anesthesia in older children. This article is an important contribution, as it is a report from a North American institution, where the threshold to proceed to circumcision has historically been lower than other countries, where the parent's desire to avoid late circumcision could potentially overstate the outcome or benefits of the topical steroid therapy. This therapy could also be applied to other foreskin problems such as persistent penile adhesions with similar expected results.

Transdermal patches can be a very precise time released method of delivering a drug. Cutting a patch in half might affect the dose delivered. The release of the active component from a transdermal delivery system (patch) may be controlled by diffusion through the adhesive which covers the whole patch, by diffusion through a membrane which may only have adhesive on the patch rim or drug release may be controlled by release from a polymer matrix. Cutting a patch might cause rapid dehydration of the base of the medicine and affect the rate of diffusion.

Topical steroids for vitiligo

topical steroids for vitiligo

Transdermal patches can be a very precise time released method of delivering a drug. Cutting a patch in half might affect the dose delivered. The release of the active component from a transdermal delivery system (patch) may be controlled by diffusion through the adhesive which covers the whole patch, by diffusion through a membrane which may only have adhesive on the patch rim or drug release may be controlled by release from a polymer matrix. Cutting a patch might cause rapid dehydration of the base of the medicine and affect the rate of diffusion.

Media:

topical steroids for vitiligotopical steroids for vitiligotopical steroids for vitiligotopical steroids for vitiligotopical steroids for vitiligo

http://buy-steroids.org